Photodynamic therapy for cervical intraepithelial neoplasia

Oncology

Volumn 69, Issue 2, 2005, Pages 110-116

  Yamaguchi, Satoshi ^a   Tsuda, Hiroshi ^b   Takemori, Masayuki ^a   Nakata, Shinich ^b   Nishimura, Sadako ^a   Kawamura, Naoki ^b   Hanioka, Keisuke ^a   Inoue, Takeshi ^b   Nishimura, Ryuichiro ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Cervical cancer; Excimer dye laser; Human papilloma virus; Photofrin; YAG OPO laser

Indexed keywords

PHOTOFRIN; VIRUS DNA;

ADULT; ARTICLE; CYTOLOGY; EXCIMER LASER; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RADIATION DOSE; SPECTRAL SENSITIVITY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; YAG LASER;

ADULT; ANTINEOPLASTIC AGENTS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DIHEMATOPORPHYRIN ETHER; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS INFECTIONS; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 25444518245     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087812     Document Type: Article

References (33)

1. Thigpen T, Vance R, Khansur T: Carcinoma of the uterine cervix: Current status and future directions. Semin Oncol 1994;21:43-56.
2. Sekiya M: Reports of the gynecologic tumor committee (in Japanese). Acta Obstet Gynaecol Jpn 2002;54:697-793.
3. Robert TG, Mary BH, Taylor M, Michael T: Cancer statistics 2001. CA Cancer J Clin 2001;51:15-36.
4. Tsuda H, Hashiguchi Y, Inoue T, Ishiko O, et al: Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm. Gynecologic Oncol 2003;91:476-485.
5. Bosch FX, Manos MM, Munoz N, Sherman M, et al: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
6. Scheffner M, Werness BA, Huibregtse JM: The E6 oncoprotein encoded by human papilloma-virus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-1136.
7. Dyson N, Howley PM, Munger K, Harlow E: The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-939.
8. 2 laser conisation of the cervix. Br J Obstet Gynecol 1993;100:717-720.
9. Dougherty TJ: Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol 1984;2:83-116.
10. Kretmer-Birnbaum M: Modified prophyrins, chorins, phtalocyanines, and purpurines: Second generation photosensitizers for photodynamic therapy. Semin Hematol 1989;26:157-173.
11. Peng Q, Berg K, Moan J, Kongshaug M, et al: 5-aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 1997;65:235-251.
12. Ichimura H, Yamaguchi S, Kojima A, Tanaka T, et al: Eradication and re-infection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia. Int J Clin Oncol 2003;8:322-325.
13. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, et al: Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991;82:524-531.
14. Nagano H, Yoshikawa H, Kawana T, Yokota H, et al: Association of multiple human papillomavirus types with vulvar neoplasias. J Obstet Gynecol Res 1996;22:1-8.
15. Monk BJ, Brewer C, VanNostrand K, Berns MW, et al: Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasia. Gynecol Oncol 1997;64:70-75.
16. Hillemanns P, Korell M, Schmitt-Sody M, Baumgartner R, et al: Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Int J Cancer 1999;81:34-38.
17. Wierrani F, Kubin A, Jindra R, Henry M, et al: 5-aminolevulinic acid-mediated photodynamic therapy of intraepithelial neoplasia and human papillomavirus of the uterine cervix: a new experimental approach. Cancer Detect Prev 1999;23:351-355.
18. Keefe KA, Tadir Y, Tromberg B, Berns M, et al: Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid. Lasers Surg Med 2002;31:289-293.
19. Barnett AA, Haller JC, Cairnduff F, Lane G, et al: A randomized, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia. Int J Cancer 2003;103:829-832.
20. Bonder K, Bonder-Adler B, Wierrani F, Kubin A, et al: Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results. Anticancer Res 2003;23:1785-1788.
21. Chang CJ, Lee YH, Yang JY, Weng CJ, et al: Pilot in vitro toxicity study of 5-ALA and photofrin in microvascular endothelial cell cultures. J Clin Laser Med Surg 1997;15:83-87.
22. Chang CJ, Sun CH, Liaw LHL, Berns MW, et al: In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells. Laser Surg Med 1999;24:178-186.
23. Muroya T, Suehiro Y, Umayahara K, Akiya T, et al: Photodynamic therapy (PDT) for early cervical cancer. Gan To Kagaku Ryoho 1996;23:47-56.
24. Di Saia PJ, Creasman WT: Preinvasive disease of the cervix; in: Clinical Gynecological Oncology, ed 4. St. Louis, Mosby Year Book, 1992, pp 1-36.
25. Boyes DA Worth AS, Fidler HK: The results of treatment of 4389 cases of preclinical squamous carcinoma. J Obstet Gynaecol Br Commonw 1970;77:769-780.
26. Creasman WT, Clarke-Pearson DL, Weed JC Jr: Results of outpatient therapy of cervical intraepithelial neoplasia. Gynecol Oncol 1981;12:306-316.
27. Bjerre B, Eliasson G, Linell F, Soderberg H, et al: Conization as only treatment of carcinoma in situ of the uterine cervix. Am J Obstet Gynecol 1976;125:143-152.
28. Ylitalo N, Josefsson A, Melbye M, Sorensen P, et al: A prospective study showing log-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 2000;60:6027-6032.
29. Schiffman MH: New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1995;87:1345-1347.
30. Melbye M, Smith E, Wohlfahrt J, Osterlind A, et al: Anal and cervical abnormality in women-prediction by human papillomavirus tests. Int J Cancer 1996;68:559-565.
31. Storey A, Thomas M, Kalita A, Harwood C, et al: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998;393:229-243.
32. Jones CM, Mang T, Cooper M, Wilson BD, et al: Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol 1992;27:979-982.
33. Wilson BD, Mang TS, Stoll H, Jones C, et al: Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 1992;128:1597-1601.